SCHEMBL6922941

SCHEMBL6922941

Cc1nc2c(C(=O)O)cccc2n1C

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.46
ALDH1A1 P00352 2/20 0.45
DHODH Q02127 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2D6 P10635 1/20 0.44
STING1 Q86WV6 1/20 0.43
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 1/20 0.41
MCL1 Q07820 1/20 0.40
RECQL P46063 1/20 0.39
TP53 P04637 1/20 0.39
FABP4 P15090 1/20 0.39
NR4A1 P22736 1/20 0.38
NR4A2 P43354 1/20 0.38
NR4A3 Q92570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10149692 0.85 PARP1 (0.61) PARP1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7477385 0.83 PARP1 (0.49) PARP1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL30437463 0.82 ALDH1A1 (0.44) PARP1ALDH1A1DHODHCYP3A4CYP2C9
SCHEMBL7568916 0.80 CNR2 (0.46) PARP1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL505230 0.80 DHODH (0.63) PARP1ALDH1A1DHODHCYP3A4CYP2C9
SCHEMBL7477457 0.80 TSHR (0.51) PARP1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL7480155 0.80 KMT2A (0.46) ALDH1A1KDM4E
SCHEMBL8952972 0.79 GABRP (0.38) ALDH1A1DHODHCYP1A2CYP3A4CYP2C9
SCHEMBL3370854 0.78 ALDH1A1 (0.41) PARP1ALDH1A1DHODHSTING1KDM4E
SCHEMBL7259712 0.77 PARP1 (0.47) PARP1ALDH1A1DHODHSTING1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115023419-A Cereblon-bound piperidine-2, 6-diones and methods of use thereof 凯普托尔治疗学股份有限公司 2022-09-06 CN disclosed
WO-2004108686-A2 BENZIMIDAZOLE COMPOUNDS HAVING HYPOGLYCEMIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-12-16 WO disclosed
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed
EP-0946519-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-06 EP disclosed
EP-0885186-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1998-12-23 EP disclosed
WO-1998024771-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-11 WO disclosed
WO-1997019911-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1997-06-05 WO disclosed